Approximately 5 million Americans have dementia, and many receive psychiatric medications. Management of such patients is complex and controversial, and it has become apparent that all potential pharmacological therapies present risks.

Breaking News

Leaders share what industry will look like in 5 to 15 years
Infusion pump maker cited for manufacturing violations
Merck’s troubled anesthesia-reversal drug plods on

Recent Headlines

Federal financial incentives spur hunt for customers’ perspectives
Panels question ‘existence and magnitude’ of drug’s overall benefit
Treatment OK’d for second-line use with Folfiri in metastatic colorectal cancer
Most states don’t allow basic EMS staff to administer injections
Mid-stage trial fails to meet primary and secondary endpoints